The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
Open accessAbstract
BACKGROUND: The neutrophil-lymphocyte ratio (NLR) has been proposed as an indicator of systemic inflammatory response. Several studies suggest a negative impact of increased NLR for patient's survival in different types of cancer. However, previous findings from small-scale studies revealed conflicting results about its prognostic significance with regard to different clinical end points in non-metastatic renal cell carcinoma (RCC) patients. Therefore, the aim of our study was the validation of the prognostic significance of NLR in a large cohort of RCC patients. METHODS: Data from 678 consecutive non-metastatic clear cell RCC patients, operated between 2000 and 2010 at a single centre, were evaluated retrospectively. Cancer-specific, metastasis-free, as well as overall survival (OS) were assessed using the Kaplan-Meier method. To evaluate the independent prognostic significance of NLR, multivariate Cox regression models were applied for all three different end points. Influence of the NLR on the predictive accuracy of the Leibovich prognosis score was determined by Harrell's concordance index. RESULTS: Multivariate analysis identified increased NLR as an independent prognostic factor for overall (hazard ratio (HR)=1.59, 95% confidence interval (CI)=1.10-2.31, P=0.014), but not for cancer-specific (HR=1.59, 95% CI=0.84-2.99, P=0.148), nor for metastasis-free survival (HR=1.39, 95% CI=0.85-2.28, P=0.184). The estimated concordance index was 0.79 using the Leibovich risk score and 0.81 when NLR was added. CONCLUSION: Regarding patients' OS, an increased NLR represented an independent risk factor, which might reflect a higher risk for severe cardiovascular and other comorbidities. Adding the NLR to well-established prognostic models such as the Leibovich prognosis score might improve their predictive ability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Evaluating the Yield of Medical Tests
Harrell, F. E. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320430047030 · Cited by 3,490
Heng, D. Y. C., Xie, W., Regan, M. M., Warren, M. A., Golshayan, A. R., Sahi, C., Eigl, B. J., Ruether, J. D., Cheng, T., North, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4809 · Cited by 2,133
Zahorec, R. (2001) · Bratislava Medical Journal · doi:10.1007/bf03656390 · Cited by 1,601
Roxburgh, C. S., & McMillan, D. C. (2010) · Future Oncology · doi:10.2217/fon.09.136 · Cited by 998
Tamhane, U. U., Aneja, S., Montgomery, D., Rogers, E.-K., Eagle, K. A., & Gurm, H. S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.006 · Cited by 900
Leibovich, B. C., Blute, M. L., Cheville, J. C., Lohse, C. M., Frank, I., Kwon, E. D., Weaver, A. L., Parker, A. S., & Zincke, H. (2003) · Cancer · doi:10.1002/cncr.11234 · Cited by 837
A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA
KATTAN, M. W., REUTER, V., MOTZER, R. J., KATZ, J., & RUSSO, P. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66077-6 · Cited by 754
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
Zisman, A., Pantuck, A. J., Dorey, F., Said, J. W., Shvarts, O., Quintana, D., Gitlitz, B. J., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1649 · Cited by 729
External validation is necessary in prediction research:
Bleeker, S. E., Moll, H. A., Steyerberg, E. W., Donders, A. R. T., Derksen-Lubsen, G., Grobbee, D. E., & Moons, K. G. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00207-5 · Cited by 710
Imtiaz, F., Shafique, K., Mirza, S., Ayoob, Z., Vart, P., & Rao, S. (2012) · International Archives of Medicine · doi:10.1186/1755-7682-5-2 · Cited by 645
Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., & von der Maase, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9498 · Cited by 461
Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting
Gibson, P. H., Croal, B. L., Cuthbertson, B. H., Small, G. R., Ifezulike, A. I., Gibson, G., Jeffrey, R. R., Buchan, K. G., El-Shafei, H., & Hillis, G. S. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.043 · Cited by 382
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
Sun, M., Shariat, S. F., Cheng, C., Ficarra, V., Murai, M., Oudard, S., Pantuck, A. J., Zigeuner, R., & Karakiewicz, P. I. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.041 · Cited by 325
Self-citationImpact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma
Donskov, F., & von der Maase, H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9594 · Cited by 299
Neutrophil-Lymphocyte Ratio as a Predictor of Adverse outcomes of Acute Pancreatitis
Azab, B., Jaglall, N., Atallah, J. P., Lamet, A., Raja-Surya, V., Farah, B., Lesser, M., & Widmann, W. D. (2011) · Pancreatology · doi:10.1159/000331494 · Cited by 282
Alkhouri, N., Morris‐Stiff, G., Campbell, C., Lopez, R., Tamimi, T. A., Yerian, L., Zein, N. N., & Feldstein, A. E. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02639.x · Cited by 256
Metastatic renal carcinoma comprehensive prognostic system
and DGCIN - German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group, Atzpodien, J., Royston, P., Wandert, T., & Reitz, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600768 · Cited by 241
Akpek, M., Kaya, M. G., Lam, Y. Y., Sahin, O., Elcik, D., Celik, T., Ergin, A., & Gibson, C. M. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.041 · Cited by 235
Ohno, Y., Nakashima, J., Ohori, M., Hatano, T., & Tachibana, M. (2010) · Journal of Urology · doi:10.1016/j.juro.2010.05.028 · Cited by 217
Keizman, D., Ish-Shalom, M., Huang, P., Eisenberger, M. A., Pili, R., Hammers, H., & Carducci, M. A. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.001 · Cited by 213
Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma
Siddiqui, S. A., Frigola, X., Bonne-Annee, S., Mercader, M., Kuntz, S. M., Krambeck, A. E., Sengupta, S., Dong, H., Cheville, J. C., Lohse, C. M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2139 · Cited by 202
Terradas, R., Grau, S., Blanch, J., Riu, M., Saballs, P., Castells, X., Horcajada, J. P., & Knobel, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042860 · Cited by 163
Sun, M., Bianchi, M., Hansen, J., Trinh, Q., Abdollah, F., Tian, Z., Sammon, J. D., Shariat, S. F., Graefen, M., Montorsi, F., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.03.051 · Cited by 149
Liotta, F., Gacci, M., Frosali, F., Querci, V., Vittori, G., Lapini, A., Santarlasci, V., Serni, S., Cosmi, L., Maggi, L., et al. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09555.x · Cited by 137
A Review of Integrated Staging Systems for Renal Cell Carcinoma
Meskawi, M., Sun, M., Trinh, Q., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.04.049 · Cited by 122
Kocyigit, I. D., Eroğlu, E., Unal, A., Sipahioğlu, M. H., Tokgöz, B., Oymak, O., & Utaş, C. (2012) · Journal of Nephrology · doi:10.5301/jn.5000152 · Cited by 111
Tsai, J. C. ‐., Sheu, S., Chiu, H., Chung, F., Chang, D., Chen, M., Shin, S., & Lee, Y. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.647 · Cited by 103
Crispen, P. L., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., & Kwon, E. D. (2008) · Cancer · doi:10.1002/cncr.23566 · Cited by 96
Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma
Hotta, K., Sho, M., Fujimoto, K., Shimada, K., Yamato, I., Anai, S., Konishi, N., Hirao, Y., Nonomura, K., & Nakajima, Y. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.368 · Cited by 92
HIGH EXPRESSION OF CHEMOKINE GENE AS A FAVORABLE PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA
Kondo, T., ITO, F., Nakazawa, H., Horita, S., Osaka, Y., & Toma, H. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000127726.25609.87 · Cited by 89
Ramsey, S., Lamb, G. W. A., Aitchison, M., & McMillan, D. C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07363.x · Cited by 84
Prognostic factors and selection for clinical studies of patients with kidney cancer
Lam, J. S., Klatte, T., Kim, H. L., Patard, J., Breda, A., Zisman, A., Pantuck, A. J., & Figlin, R. A. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.08.003 · Cited by 81
Pichler, M., Hutterer, G. C., Chromecki, T. F., Jesche, J., Kampel‐Kettner, K., Rehak, P., Pummer, K., & Zigeuner, R. E. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.07.034 · Cited by 76
Self-citationJagdev, S., Gregory, W. M., Vasudev, N. S., Harnden, P., Sim, S., Thompson, D., Cartledge, J. J., Selby, P. J., & Banks, R. E. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605973 · Cited by 73
Exercise and immune function: effect of ageing and nutrition
Pedersen, B. K., Brüünsgaard, H., Jensen, M. S., Krzywkowski, K., & Ostrowski, K. (1999) · Proceedings of The Nutrition Society · doi:10.1017/s0029665199000968 · Cited by 31
What do we mean by validating a prognostic model?
(2000) · doi:10.1002/(sici)1097-0258(20000229)19:4<453::aid-sim350>3.0.co;2-5
Cited by
Templeton, A. J., McNamara, M. G., Šeruga, B., Vera-Badillo, F. E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J. J., Tran, B., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju124 · Cited by 2,829
Neutrophil-to-lymphocyte ratio, past, present and future perspectives
Zahorec, R. (2021) · Bratislava Medical Journal · doi:10.4149/bll_2021_078 · Cited by 885
Templeton, A. J., Ace, O., McNamara, M. G., Al-Mubarak, M., Vera-Badillo, F. E., Hermanns, T., Šeruga, B., Ocaña, A., Tannock, I. F., & Amir, E. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0146 · Cited by 719
Stotz, M., Gerger, A., Eisner, F., Szkandera, J., Loibner, H., L Ress, A., Kornprat, P., A Zoughbi, W., Seggewies, F. S., Lackner, C., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.332 · Cited by 490
Self-citationParamanathan, A., Saxena, A., & Morris, D. L. (2014) · Surgical Oncology · doi:10.1016/j.suronc.2013.12.001 · Cited by 316
Metadata
- Authors
- Pichler, M., Hutterer, G. C., Stoeckigt, C., Chromecki, T. F., Stojakovic, T., Golbeck, S., Eberhard, K., Gerger, A., Mannweiler, S., Pummer, K., & Zigeuner, R.
- Venue
- British Journal of Cancer
- Published
- 2013-02-05
- Volume
- 108
- Issue
- 4
- Pages
- 901-907
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1993013170
- Cited by
- 275
- References
- 38
- FWCI
- 17.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.